GlassScriptPhysician profile
Xi Bei Tian
NPI 1316238090
$1,088.23
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $780 · 2020: $130 · 2021: $67.24 · 2022: $40.36 · 2023: $70.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $70.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $70.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $223.41 | 2019-2023 | Proclaim |
| Nevro Corp. | $183.59 | 2019 | |
| Vertiflex, INC. | $120.17 | 2019 | |
| Medtronic USA, INC. | $90.96 | 2019-2020 | |
| Lilly USA, LLC | $90.47 | 2019-2021 | |
| Boston Scientific Corporation | $69.84 | 2019 | |
| Collegium Pharmaceutical, INC. | $48.41 | 2019-2022 | |
| Mdd US Operations, LLC | $47.35 | 2019-2020 | |
| Medtronic, INC. | $44.06 | 2021 | |
| Pfizer INC. | $41.60 | 2019 | |
| Stimwave Technologies Incorporated | $31.39 | 2019 | |
| Daiichi Sankyo INC. | $26.06 | 2019 | |
| Bioventus LLC | $22.84 | 2019 | |
| Supernus Pharmaceuticals, INC. | $20.97 | 2019 | |
| Merck Sharp & Dohme LLC | $14.37 | 2023 | Bridion |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $12.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xi Tian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.